Brief: Clearmind Medicine Files International Patent Application For Novel Combination Therapy Targeting Weight Loss And Fatty Liver Disease
30/07/2025 14:14
July 30 (Reuters) - Clearmind Medicine Inc CMND.O: CLEARMIND MEDICINE FILES INTERNATIONAL PATENT APPLICATION FOR NOVEL COMBINATION THERAPY TARGETING WEIGHT LOSS AND FATTY LIVER DISEASE Source text: ID:nGNX1WzY9c Further company coverage: CMND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM